Abstract
Hyperhomocysteinemia (HHcy) is considered a risk factor for cardiovascular disease (CVD), including chronic kidney disease (CKD). In this study, we investigated the association between levels of serum homocysteine (Hcy) and mortality, inferred from the presence of CKD. Our study included data of 9895 participants from the 1999 to 2016 National Health and Nutrition Examination Surveys (NHANES). Multivariable-adjusted Cox proportional hazard models using propensity-score, were used to examine dose-response associations between Hcy level and mortality. A total of 9895 participants, 1025 (10.3%) participants were diagnosed with CKD. In a multivariate Cox regression analysis including all participants, Hcy level was significantly associated with all-cause mortality in the nonCKD group, compared to the 1st quartile in the fully adjusted model (2nd quartile: hazard ratio (HR) 1.75, 95% confidence interval (CI) 1.348-2.274, P
Author supplied keywords
Cite
CITATION STYLE
Song, J. H., Huh, H., Bae, E., Lee, J., Lee, J. P., Lee, J. S., … Yoo, K. D. (2022). Association between homocysteinemia and mortality in CKD: A propensity-score matched analysis using NHANES-National Death Index. Medicine (United States), 101(36), E30334. https://doi.org/10.1097/MD.0000000000030334
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.